Medtronic plc (MDT) Announces FDA Approval for SmartGuard Algorithm as Automated Glycemic Controller
Medtronic plc (NYSE:MDT) is one of the 14 Tech Stocks to Sell Now According to Ken Fisher. On September 2, 2025, Medtronic plc (NYSE:MDT) announced that the FDA cleared its SmartGuard algorithm as an ...
MiniMed 640G system with SmartGuard for managing blood glucose levels in people with type 1 diabetes
The MiniMed 640G integrated sensor‑augmented pump therapy system with SmartGuard is a continuous glucose monitoring and insulin delivery system for people with type 1 diabetes. It can automatically ...
It’s notoriously difficult to manage blood sugar levels in children and teenagers with Type 1 diabetes because of their high activity levels, constantly fluctuating hormones and ongoing growth and ...
It’s traditionally been particularly difficult to manage diabetes in highly active, still-developing children, but increasingly advanced glucose monitors and insulin delivery systems are aiming to ...
Medtronic plc (NYSE:MDT) is one of the 14 Tech Stocks to Sell Now According to Ken Fisher. On September 2, 2025, Medtronic plc (NYSE:MDT) announced that the FDA cleared its SmartGuard algorithm as an ...
DUBLIN, June 11, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (MDT), the global leader in medical technology, today announced CE (Conformité Européenne) Marking of its MiniMed™ 780G system, a next ...
Medtronic plc (MDT) Announces FDA Approval for SmartGuard Algorithm as Automated Glycemic Controller
On September 2, 2025, Medtronic plc (NYSE:MDT) announced that the FDA cleared its SmartGuard algorithm as an interoperable automated glycemic controller, allowing its integration with Abbott’s ...
MiniMed 640G system with SmartGuard for managing blood glucose levels in people with type 1 diabetes
A search of the Medicines and Healthcare Products Regulatory Agency website revealed 1 Field Safety Notice (MHRA reference: 2015/009/028/292/033) for the MiniMed 640G insulin pump (MMT‑1711 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results